AIML.CN AI/ML Innovations Inc CNQ 23 Jan 2026: Trades C$0.035, AI stocks view

AIML.CN stock trades at C$0.035 on CNQ during market hours on 23 Jan 2026. Volume is active at 622,848 shares versus an average of 378,714, which shows above‑average trading interest. The company, AI/ML Innovations Inc., sits in the Healthcare sector but competes in AI-driven digital health tools. Fundamentals show a negative EPS of -0.03 and a small market cap of C$5,889,240.00, so risk is high. We review valuation, technicals, Meyka AI grading, and our scenario targets for AI investors.

AIML.CN stock: price, liquidity and intraday flow

Current price is C$0.035, unchanged from the previous close on 23 Jan 2026. Volume of 622,848 is 1.64x average volume, signaling higher intraday interest.

Trading range today is narrow at C$0.035 to C$0.035. The 50‑day average is C$0.03810 and the 200‑day average is C$0.05775, both above the current price which signals short-term weakness.

AIML.CN stock fundamentals and valuation

AI/ML Innovations Inc shows a market cap of C$5,889,240.00 and 168,264,000 shares outstanding. Reported EPS is -0.03 and trailing P/E reads -1.13, reflecting losses.

Key value metrics include P/S 35.00 and P/B 4.58. These ratios are weak relative to the Healthcare sector average P/B of 1.46 and average P/E of 14.42. The company also reports cash per share C$0.005 and negative operating cash flow per share C$-0.02635.

AIML.CN stock technicals and market signals

Short-term momentum is muted. RSI is 40.70, ADX is 14.53 indicating no clear trend, and MACD is flat. Bollinger bands sit around C$0.04/C$0.03, showing low intraday volatility.

On‑balance volume is negative at -3,369,524, which points to distribution over time. Relative volume of 1.64 combined with a low price highlights speculative trading and high volatility risk.

Meyka AI grade and forecast for AIML.CN stock

Meyka AI rates AIML.CN with a score out of 100. Meyka AI rates AIML.CN with a score of 58.11, a C+ grade and a HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects C$0.01710 for 12 months. Versus the current C$0.035, that implies a downside of -51.16%. Forecasts are model‑based projections and not guarantees.

AIML.CN stock risks, catalysts and scenario price targets

Principal risks include small market cap, negative earnings, thin institutional coverage, and competition in AI healthcare solutions. The company lists a patent‑pending monitoring system but has limited scale and no full‑time employees disclosed.

Scenario targets for traders: Bull case C$0.08, Base case C$0.035, Bear case C$0.017. Use tight risk controls and position sizing when trading AIML.CN stock because liquidity and volatility are material factors.

News context and sector signals for AIML.CN stock

Macro AI headlines continue to shape sentiment across small AI plays. Broader AI coverage from major outlets is active this week and may lift attention to AI health names source and Reuters source.

Sector data shows Healthcare averages are mixed and the AI/ML subtheme sits between Technology and Healthcare trends. AIML.CN stock remains more speculative than industry peers due to size and negative margins.

Final Thoughts

Key takeaways for AIML.CN stock: the share trades at C$0.035 on CNQ with above‑average intraday volume, but fundamentals remain weak with EPS -0.03 and stretched valuation ratios like P/S 35.00 and P/B 4.58. Meyka AI rates AIML.CN with a 58.11 score (Grade C+) and issues a model projection of C$0.01710 for the next 12 months, implying -51.16% downside versus the current price. That projection highlights downside risk for buy‑and‑hold investors.

For AI sector traders, AIML.CN stock offers speculative upside if the company commercializes its patent‑pending monitoring system or secures partnerships. We recommend defined position sizing, stop discipline, and monitoring of news catalysts and quarterly updates. Use Meyka AI as an AI‑powered market analysis platform for ongoing alerts and price‑action monitoring. Forecasts are model projections and not guarantees; perform your own research before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.